Loading provider…
Loading provider…
Cardiovascular Disease Physician in Amarillo, TX
NPI: 1447424007Primary Practice Location
Cca ASC, LLC
6200 W I-40, Amarillo, TX
Primary Employer
Cardiology Center of Amarillo
ccallp.com
HQ Phone
Get DO David's Phone Numberphone_androidMobile
Get DO David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License

TX State License
2007 - 2025

NM State License
2015 - 2016
University of Rochester Medical Center
urmc.rochester.edu
Fellowship • Interventional Cardiology
2010 - 2011
Baylor Scott & White Medical Center - Baylor College of Medicine (Temple)
Fellowship • Cardiovascular Disease
2007 - 2010
Residency • Internal Medicine
2004 - 2007
Texas College of Osteopathic Medicine
unthsc.edu
Medical School
Until 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 683 | 829 |
| 2 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 450 | 590 |
| 3 | 78431Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 360 | 362 |
| 4 | 78434Nuclear medicine absolute quantification of blood flow in heart muscle | 359 | 361 |
| 5 | 99490Chronic care management services at least 20 minutes per calendar month | 299 | 2,619 |
Impella RP: A Promising Intervention in Acute Right Ventricular Failure Caused by Massive Pulmonary Embolism.
Authors: Assad Mohammedzein
Publication Date: 2019-07-10
Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest.
Authors: Khan, Muhammad Atif, Khan, Faiza Humayun, Khan, Hina Benish, Brabham, David
Journal: Cureus
Publication Date: 2023-04-23
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: LY3540378